Among OHGA-treated participants, deaths due to dementia and renal disease were common (~22% and ~8%, respectively), whereas among those treated with insulin therapy, infectious causes and renal disease were more common (~29% and ~13%, respectively). This evidence concerns the gene INS and kidney disorder.